Imran Rafi
Impact in
-
- Electronic Health Records Systems
-
- BRCA gene mutations in cancer
- Hemoglobinopathies and Related Disorders
Papers in
- Genetics 13
- BRCA gene mutations in cancer 10
- Genomics and Rare Diseases 7
-
- Ethics in Clinical Research 3
- Co-authors
- John Davies (1 shared paper)Jennie Wimperis (1 shared paper)Shamez Ladhani (1 shared paper)Paula Bolton‐Maggs (1 shared paper)Michael Lewis (1 shared paper)Simon de Lusignan (13 shared papers)Simon Jones (7 shared papers)Alan V. Boddy (5 shared papers)
- Journals
- British Journal of General Practice (12 papers)BMJ Open (4 papers)BMJ (2 papers)Kidney International (2 papers)JMIR Public Health and Surveillance (2 papers)
- Partner nations
- United KingdomCanadaUnited States
In The Last Decade
Imran Rafi
46 papers receiving 977 citations
Peers
Comparison fields: 5 of 105
- Health Information Management 84
- Genetics 57
- Hematology 51
- Oncology 116
- Medical Terminology 1
Countries citing papers authored by Imran Rafi
This map shows the geographic impact of Imran Rafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imran Rafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imran Rafi more than expected).
Fields of papers citing papers by Imran Rafi
This network shows the impact of papers produced by Imran Rafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imran Rafi. The network helps show where Imran Rafi may publish in the future.
Co-authors
The 25 scholars most cited alongside Imran Rafi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 228 | |
| 2 | 2014 | 175 | |
| 3 | 2013 | 53 | |
| 4 | 2003 | 51 | |
| 5 | 2013 | 42 | |
| 6 | Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3, 4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridylthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion. | 1995 | 35 |
| 7 | 2020 | 34 | |
| 8 | 1998 | 33 | |
| 9 | 2021 | 32 | |
| 10 | 2016 | 31 | |
| 11 | Phase I studies with the nonclassical antifolate nolatrexed dihydrochloride (AG337, THYMITAQ) administered orally for 5 days. | 1999 | 30 |
| 12 | 2012 | 24 | |
| 13 | 2009 | 19 | |
| 14 | 2016 | 18 | |
| 15 | 2020 | 15 | |
| 16 | 2018 | 14 | |
| 17 | 2018 | 14 | |
| 18 | 2014 | 14 | |
| 19 | 2012 | 13 | |
| 20 | 2013 | 13 |
About Imran Rafi
Imran Rafi is a scholar working on Genetics, Public Health, Environmental and Occupational Health, Oncology, Epidemiology and Infectious Diseases, having authored 50 papers that have together received 1.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (10 papers), Genomics and Rare Diseases (7 papers), Chronic Kidney Disease and Diabetes (3 papers), Blood Pressure and Hypertension Studies (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Ethics in Clinical Research (3 papers), Primary Care and Health Outcomes (2 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Health Information Management (84 citations), Genetics (57 citations), Hematology (51 citations), Oncology (116 citations) and Medical Terminology (1 citation). Imran Rafi has collaborated with scholars based in United Kingdom, Canada and United States. Frequent co-authors include John Davies, Jennie Wimperis, Shamez Ladhani, Paula Bolton‐Maggs, Michael Lewis, Simon de Lusignan, Simon Jones, Alan V. Boddy, Aziz Sheikh and G. A. Taylor. Their work appears in journals such as British Journal of General Practice, BMJ Open, BMJ, Kidney International and JMIR Public Health and Surveillance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.